Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc at Citi Healthcare Conference (Virtual) Transcript

Feb 24, 2022 / 04:00PM GMT
Release Date Price: €91.38 (-4.93%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Good morning, everybody. I actually just had to check the time to make sure it's still morning with everything going on. But I am Joanne Wuensch, the med tech analyst at Citi, if people don't hear me, but I'm very pleased to be kicking off this session with the management team of Tandem, including John Sheridan; Leigh Vosseller; and Susan Morrison. So everybody, thank you, and welcome.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Good to see you, Joanne.

Questions & Answers

Joanne Karen Wuensch;Leigh A. Vosseller
Citigroup Inc., Research Division - MD;Tandem Diabetes Care, Inc. -

I have a lot of questions about COVID and the insulin market or the insulin pump market, but I do want to start a little bit to think about your guidance. And how you put it all together, given all the many headwinds that you have, which is moving on. So I think that's a great place to lead with that.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot